Daiwa Securities Group Inc. boosted its position in Cooper Companies, Inc. (The) (NYSE:COO) by 74.1% during the second quarter, Holdings Channel reports. The fund owned 2,350 shares of the medical device company’s stock after buying an additional 1,000 shares during the period. Daiwa Securities Group Inc.’s holdings in Cooper Companies, Inc. (The) were worth $563,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in COO. Bessemer Group Inc. raised its position in Cooper Companies, Inc. (The) by 39.1% in the second quarter. Bessemer Group Inc. now owns 575,951 shares of the medical device company’s stock worth $137,895,000 after buying an additional 161,772 shares during the period. CAPROCK Group Inc. bought a new position in Cooper Companies, Inc. (The) during the second quarter worth $212,000. CIBC Asset Management Inc raised its position in Cooper Companies, Inc. (The) by 0.3% in the second quarter. CIBC Asset Management Inc now owns 4,697 shares of the medical device company’s stock worth $1,125,000 after buying an additional 16 shares during the period. Rothschild Asset Management Inc. raised its position in Cooper Companies, Inc. (The) by 6.5% in the second quarter. Rothschild Asset Management Inc. now owns 116,899 shares of the medical device company’s stock worth $27,988,000 after buying an additional 7,170 shares during the period. Finally, Great West Life Assurance Co. Can raised its position in Cooper Companies, Inc. (The) by 3.1% in the second quarter. Great West Life Assurance Co. Can now owns 28,335 shares of the medical device company’s stock worth $6,779,000 after buying an additional 857 shares during the period. 99.97% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Cooper Companies, Inc. (COO) opened at 240.92 on Friday. Cooper Companies, Inc. has a 12 month low of $158.73 and a 12 month high of $256.39. The firm has a market capitalization of $11.77 billion, a price-to-earnings ratio of 36.12 and a beta of 0.61. The firm’s 50-day moving average price is $245.14 and its 200-day moving average price is $214.89.

Cooper Companies, Inc. (The) (NYSE:COO) last announced its quarterly earnings results on Thursday, June 1st. The medical device company reported $2.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.25 by $0.25. Cooper Companies, Inc. (The) had a return on equity of 15.88% and a net margin of 16.02%. The company had revenue of $522.40 million during the quarter, compared to the consensus estimate of $520.71 million. During the same period in the prior year, the company earned $2.05 earnings per share. The company’s revenue for the quarter was up 8.0% compared to the same quarter last year. On average, equities analysts anticipate that Cooper Companies, Inc. will post $9.63 earnings per share for the current year.

The firm also recently declared a semiannual dividend, which was paid on Monday, August 7th. Shareholders of record on Friday, July 21st were issued a $0.03 dividend. The ex-dividend date of this dividend was Wednesday, July 19th. This represents a dividend yield of 0.02%. Cooper Companies, Inc. (The)’s dividend payout ratio (DPR) is currently 0.90%.

WARNING: This report was originally posted by Daily Political and is the sole property of of Daily Political. If you are accessing this report on another site, it was illegally copied and reposted in violation of US and international trademark and copyright law. The correct version of this report can be viewed at https://www.dailypolitical.com/2017/08/13/cooper-companies-inc-the-nysecoo-shares-bought-by-daiwa-securities-group-inc.html.

A number of equities analysts recently weighed in on COO shares. J P Morgan Chase & Co reiterated a “neutral” rating and issued a $206.00 price target (up previously from $200.00) on shares of Cooper Companies, Inc. (The) in a research report on Monday, June 5th. Jefferies Group LLC reiterated a “buy” rating and issued a $250.00 price target (up previously from $220.00) on shares of Cooper Companies, Inc. (The) in a research report on Saturday, June 3rd. Zacks Investment Research upgraded Cooper Companies, Inc. (The) from a “hold” rating to a “buy” rating and set a $243.00 price target for the company in a research report on Tuesday, May 23rd. BMO Capital Markets reiterated a “buy” rating and issued a $255.00 price target on shares of Cooper Companies, Inc. (The) in a research report on Thursday, July 13th. Finally, Oppenheimer Holdings, Inc. set a $225.00 price target on Cooper Companies, Inc. (The) and gave the company a “hold” rating in a research report on Saturday, June 3rd. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $242.00.

In other Cooper Companies, Inc. (The) news, EVP Carol R. Kaufman sold 5,408 shares of the stock in a transaction dated Friday, June 9th. The stock was sold at an average price of $240.86, for a total value of $1,302,570.88. Following the completion of the sale, the executive vice president now directly owns 49,327 shares in the company, valued at $11,880,901.22. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Carol R. Kaufman sold 44,092 shares of the stock in a transaction dated Thursday, June 8th. The stock was sold at an average price of $242.81, for a total value of $10,705,978.52. Following the completion of the sale, the executive vice president now owns 60,419 shares of the company’s stock, valued at $14,670,337.39. The disclosure for this sale can be found here. Insiders sold 67,331 shares of company stock valued at $16,400,454 over the last 90 days. Corporate insiders own 1.60% of the company’s stock.

Cooper Companies, Inc. (The) Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies, Inc. (The) (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with MarketBeat.com's FREE daily email newsletter.